IL-31 Receptor Alpha Expression in Epidermal Keratinocytes Is Modulated by Cell Differentiation and Interferon Gamma
Authors:
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (1) , 240-243
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel diseaseGut, 2007
- Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31Experimental Hematology, 2007
- Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial CellsJournal of Biological Chemistry, 2007
- Complete overlap of interleukin-31 receptor A and oncostatin M receptor β in the adult dorsal root ganglia with distinct developmental expression patternsNeuroscience, 2006
- IL-31 is associated with cutaneous lymphocyte antigen–positive skin homing T cells in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2006
- Effects of the differentiated keratinocyte phenotype on expression levels of CYP1–4 family genes in human skin cellsToxicology and Applied Pharmacology, 2005
- Retinoic Acid and its 4-Oxo Metabolites are Functionally Active in Human Skin Cells In VitroJournal of Investigative Dermatology, 2005
- Characterization of the Signaling Capacities of the Novel gp130-like Cytokine ReceptorJournal of Biological Chemistry, 2004
- Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceNature Immunology, 2004
- GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor ReceptorJournal of Biological Chemistry, 2003